Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Session XIV: BCL2 as Target

Saturday, October 21, 2023
9:45 AM – 11:20 AM ET
Location: Metropolitan East

Presentations:

  • 9:45 AM – 9:50 AM ET
    Welcome
  • 9:50 AM – 10:10 AM ET
    The Prince Family Lecture: BCL2 in CLL: Function, Targeting, and Resistance

    Speaker: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School

  • 10:10 AM – 10:30 AM ET
    Venetoclax: What is the Optimal Duration of Treatment? What is the Role of MRD in Determining Duration?

    Speaker: Othman Al-Sawaf, MD – University Hospital of Cologne

  • 10:30 AM – 10:45 AM ET
    Debate: BTKi vs BCL2i: Round 2 - BTKi

    Debate Speaker: Javier Pinilla Ibarz, MD, PhD – Moffitt Cancer Center

  • 10:45 AM – 11:00 AM ET
    Debate: BTKi vs BCL2i: Round 2 - BCL2i

    Debate Speaker: Asher Chanan-Khan, MD – Mayo Clinic

  • 11:00 AM – 11:20 AM ET
    Panel Discussion

    Moderator: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School

    Panelist: Othman Al-Sawaf, MD – University Hospital of Cologne

    Panelist: Asher Chanan-Khan, MD – Mayo Clinic

    Panelist: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute / Harvard Medical School

    Panelist: Javier Pinilla Ibarz, MD, PhD – Moffitt Cancer Center